American Journal of Neuroradiology 23:978-981, June-July 2002
© 2002 American Society of Neuroradiology
Technical Note
INTERVENTIONAL
Hemostatic Closure Device after Carotid Puncture for Stent and Coil Placement in an Intracranial Aneurysm: Technical Note
Raphaël Blanca,
Charbel Mounayera,
Michel Piotina,
Jean-Claude Sadikb,
Laurent Spellea and
Jacques Moreta
a Departments of Interventional Neuroradiology, Fondation Rothschild, Paris, France
b Diagnostic Radiology, Fondation Rothschild, Paris, France
Address reprint requests to Jacques Moret, MD, Service de Neuroradiologie Interventionnelle, Hôpital de la Fondation Ophtalmologique Adolphe de Rothschild, 75940 Paris Cedex 19, France
 |
Abstract
|
|---|
Summary: A 71-year-old female patient presented with a wide-necked
carotid cavernous aneurysm for which stent and coil placement
was planned. Arterial tortuosity required direct puncture of
the common carotid artery for access. The procedure was performed
while the patient was receiving antiplatelet and anticoagulative
therapy. To avoid potentially hazardous and prolonged carotid
compression, a closure device (Angio-Seal) was used at the end
of the procedure. The postoperative period was clinically uneventful.
Sonographic and angiographic follow-up of the carotid artery
were performed.
 |
Introduction
|
|---|
Some endovascular treatments in the field of interventional
neuroradiology are more likely to require heparinization and
antiplatelet therapy during and after the procedure, putting
the patients at risk of bleeding from the puncture site after
sheath removal. With the advent of intracranial stent placement
requiring strong anticoagulation and antiplatelet regimen during
and after angioplasty, the potential for significant morbidity
is increasing. Consequently, it is important to favor the conditions
of rapid local hemostasis for prompt sheath removal after intervention.
In recent years, percutaneous devices have been developed to
reduce time to hemostasis. The devices have provided the ability
to safely remove femoral sheaths from patients receiving anticoagulative
medication immediately after the procedure, without having to
reverse anticoagulation. For endovascular treatment of cerebrovascular
diseases, vessel tortuosity may prevent successful access via
the femoral route and, in some circumstances, direct puncture
of the supra-aortic vessels is advocated to access the targeted
lesion. We report the case of a 71-year-old patient who presented
with a wide necked carotid-cavernous aneurysm for which a closure
device was used immediately after stent and coil placement in
the aneurysm via transcarotid and transfemoral approaches.
 |
Report of the Technique
|
|---|
A 71-year-old woman was referred to our department for endovascular
treatment of a symptomatic (diplopia) right-sided carotid cavernous
aneurysm. The results of a neurologic examination were consistent
with a right third nerve palsy. Because of the wide neck of
the aneurysm, primary stent placement in the carotid artery
at the level of the aneurysm neck was planned. The stent placement
would have allowed further safe coil deposition into the sac,
avoiding coil protrusion into the carotid lumen. With the patient
under general anesthesia, a 6-French guiding catheter (Envoy;
Cordis, Miami Lakes, FL) was positioned into the right common
carotid artery via a right femoral approach. Because of the
supra-aortic vessel tortuosity, difficulty of stent tracking
and delivery was anticipated, and a direct puncture of the right
common carotid artery was performed to allow the placement of
a 6-French sheath. Once the right common carotid artery was
punctured, a .035 hydrophilic angulated guidewire (Radiofocus/Terumo
Corporation, Tokyo, Japan) was navigated into the distal cervical
carotid artery under road mapping control. Next, a 6-French
sheath (Radiofocus/Terumo Corporation) was carefully advanced
over the wire so that its distal tip was positioned into the
origin of the right internal carotid artery. Once the carotid
sheath was in position, IV anticoagulative treatment was initiated
(a bolus of 5000 IU of heparin and then an immediate infusion
of 3000 IU/hr, a bolus of 250 mg of aspirin). This sheath allowed
the advancement of a second 6-French Envoy guiding catheter
into the petrous segment of the right internal carotid artery.
Under road mapping control, a balloon-expandable 18-mm-long
coronary stent with a 4-mm diameter (S670; Medtronic/AVE, Santa
Rosa, CA) was navigated into the cavernous portion of the right
internal carotid artery over a .014-inch guidewire (Transend,
Boston/Target, Fremont, CA). Once in position, the stent was
delivered by balloon inflation so that it fully covered the
neck of the aneurysm. A 20-mm Equinox balloon microcatheter
(Micro Therapeutics Inc., Irvine, CA) was then navigated inside
the deployed stent. Via the right femoral route, an Excelsior
microcatheter (Boston/Target) was navigated into the aneurysm
sac through the stent mesh. The aneurysm was subsequently packed
with mechanically detachable coils (DCS-18; William COOK Europe
A/S, Bjaeverskov, Denmark) and Guglielmi detachable coil (Boston/Target)
by using the remodeling technique so that it avoided inadvertent
coil protrusion through the stent strut into the carotid lumen
(
Fig 1). When the control angiogram attested to the circulatory
exclusion of the aneurysm, the procedure was discontinued. To
allow rapid and safe hemostasis, an Angio-Seal (Daig/St. Jude
Medical, St. Paul, MN) closure device was placed at the site
of the carotid puncture (
Fig 2). The femoral puncture site was
also closed with the same device. After an observation period
of 1 hr to rule out any bleeding at the level of the neck, the
patient was extubated. Full heparinization was administered
for an additional 3 days so that partial thromboplastin time
was maintained between 1.5 and 2 times baseline values. Three
hours after the end of the procedure, 70 mg of Clopidogrel bisulfate
(Plavix, Sanofi-Synthelabo, Paris, France) was orally administered.
The administration of Clopidogrel (70 mg/day) was maintained
for 1 month. A regimen of orally administered aspirin (250 mg/day)
was started the day after the intervention and was maintained
for 3 months. At day 5 after endovascular treatment, follow-up
duplex Doppler sonography of the right common carotid artery
was performed. The anchor appeared as a hyperechoic structure
with shadowing, and a color signal was noted as a rapidly changing
mixture of red and blue behind it. The color artifact reported
herein corresponded to the color Doppler twinkling artifact
described by Rahmouni et al. These authors showed that artifactual
color appears to be generated at random, strongly reflecting
a medium composed of individual reflectors (
Fig 3). Color Doppler
sonography was performed after 3 months and showed the total
resorption of the anchor and persistence of the collagen plug
at the outer surface of the carotid artery (
Fig 4). The 3-month
follow-up angiographic findings of the carotid artery were normal
(
Fig 5).

View larger version (169K):
[in this window]
[in a new window]
|
FIG 1. Radiograph of the skull shows coiling of the aneurysm with the remodeling technique. Guiding catheter has been advanced into the petrous portion of the right internal carotid artery to facilitate stent delivery across the aneurysm neck.
| |

View larger version (101K):
[in this window]
[in a new window]
|
FIG 2. Photograph of the patients neck immediately after the carotid closure shows the external part of the Angio-Seal device. The tension spring (thick arrow) is positioned between the tamper tube compactor (open arrow) and the crimp stop (arrowhead) for 20 min to compact the collagen plug against the adventia of the artery. The bioabsorbable Dexon (polyglycolic acid) suture (thin arrow) is then cut, and the tamper tube compactor is discarded.
| |

View larger version (104K):
[in this window]
[in a new window]
|
FIG 3. Duplex Doppler sonogram of the puncture site, obtained at day 5 after the procedure, shows normal flow velocity inside the carotid lumen. Twinkling artifact (thick arrow) is observed immediately behind the hyperechoic signal of the anchor (arrowheads).
| |

View larger version (133K):
[in this window]
[in a new window]
|
FIG 4. Three-month follow-up color Doppler sonogram of the carotid artery shows that the anchor has totally resorbed. The external collagen plug is persisting and appears as a hypoechoic structure (thick arrow).
| |
 |
Discussion
|
|---|
The use of direct access via the common carotid artery allows
some intracranial procedures that would not otherwise be feasible
because of difficult or even impossible navigation through tortuous
vessels. On a regular basis for patients in whom we encounter
difficulties to position a guiding catheter into the carotid
artery via a femoral approach, we consider direct carotid approach
after common carotid artery puncture. This technique is facilitated
by the use of road mapping control because a diagnostic catheter
has been anchored at the origin of the targeted common carotid
artery via a femoral approach. The navigation of commercially
available stents, which are potentially suitable for neurointerventional
procedures, is still a matter of major concern. The trackability
of a premounted stent on a balloon microcatheter is in many
instances difficult and requires the advancement of the guiding
catheter distally into the internal carotid artery. In our case,
the 6-French guiding catheter was carefully advanced and positioned
in the horizontal segment of the right carotid artery. This
was not possible from the femoral route and required common
carotid artery access. Anticoagulation with full heparinization
is mandatory during intracranial stent delivery, and strong
antiplatelet regimen during and after stent implantation is
also advocated. Consequently, sheath removal from these patients
is critical. Although deferring sheath removal and sending the
patients back to the intensive care unit with the sheath sutured
in the groin has been a common practice in interventional neuroradiology
but has exposed these patients to thromboembolic complications,
hematoma formation, retroperitoneal hemorrhage, or infection.
It has been reported that

78% of femoral arterial sheaths left
in place overnight develop significant clots, even when the
sheath is perfused with heparinized saline. Anticoagulation
with heparin and the use of new platelet-inhibiting strategies
have led to a higher incidence of puncture site bleeding complications
after intracranial angioplasty and stent deployment and have
advocated the use of hemostatic closure devices. In our case,
manual compression of the carotid artery would have resulted
in an important flow reduction in the downstream territory (especially
because prolonged compression time was expected) and could have
compromised immediate stent patency by flow reduction and subsequent
potential stent thrombosis. Moreover, prolonged manual carotid
compression can be deleterious to the patients neurologic
status because cerebral flow impairment may lead to brain ischemic
insult, particularly in cases in which the anterior communicating
artery and ipsilateral posterior communicating artery are not
functional. Hence, if manual compression is not efficient enough,
the patient is exposed to the risk of neck hematoma and tracheal
compression. Therefore, keeping in mind the need to obtain quick
hemostasis and patency of the stent, we thought to apply the
Angio-Seal hemostatic closure device to the carotid arteriotomy
in the same manner in which we had applied it to the femoral
access. According to the manufacturer, this hemostatic puncture
closure device is a bioabsorbable, sheath-delivered vascular
device that deposits an anchor (50% lactide/50% glycolide copolymer)
attached by an absorbable suture intraluminally against the
inner arterial wall and a small collagen plug on the external
surface of the artery. As the sheath and carrier tube of the
Angio-Seal system are removed, the anchor and the collagen plug
are drawn together and the arterial puncture site is mechanically
sealed (sandwich technique). According to the manufacturer,
in an artery with a 9-mm diameter, the anchor of a 6-French
Angio-Seal device occupies 4% of the lumen. Softening of the
anchor by water absorption starts as soon as the first hours,
and encapsulation of the anchor by endothelial cells is noted
within the first 7 days so that it is excluded from the blood
stream. The absorption of the anchor is complete with healing
of the arterial wall in <90 days. The collagen plug, which
is in contact with the adventia of the artery, resorbs during
a longer period of time.
The use of the Angio-Seal device for femoral closure has gained acceptance because it offers safe and quick hemostasis and better comfort for the patient than do suture-mediated hemostatic closure devices. The complication rate is low, but complications include AVF, pseudoaneurysm, hematoma, and flow impairment with resulting ischemia. Direct thrombosis at the anchor site and distal emboli (from intraluminal collagen plug protrusion, thrombi, or anchor migration) have been considered responsible for severe ischemia in peripheral vessels. It is hoped that as physicians become more experienced and as this device technically improves, complications will significantly decrease. The learning curve of implantation is the critical factor influencing the safety of the Angio-Seal device. Because an ischemic complication in the carotid artery territory could have been catastrophic with few therapeutic resources, careful and cautious delivery was performed by a senior interventional neuroradiologist who had extensive experience with use of the Angio-Seal device in the femoral artery. Immediate and mid-term clinical and sonographic follow-up confirmed that the carotid lumen and flow were not compromised by the anchor and that the collagen plug was in an adequate position. At the 3-month follow-up, the anchor had completely resorbed, with restitution of the normal arterial wall whereas the collagen plug was still present on the external side of the arterial wall. This closely corresponded to a previous sonographic description at the level of the femoral artery.
 |
Conclusion
|
|---|
In this patient, use of the Angio-Seal device allowed us to
achieve immediate hemostasis after percutaneous puncture and
catheterization of the common carotid artery with a 6-French
sheath while maintaining both anticoagulation and antiplatelet
therapy. It avoided the need for prolonged manual compression
of the carotid artery, which impairs downstream flow of the
cerebral circulation and could be deleterious to the patients
neurologic condition.
 |
References
|
|---|
-
Rahmouni A, Bargoin R, Herment A, Bargoin N, Vasile N. Color Doppler twinkling artifact in hyperechoic regions.
Radiology1996; 199
:269
271[Abstract/Free Full Text]
-
Koenigsberg RA, Wysoki M, Roth T, et al. Clot formation in femoral arterial sheaths maintained overnight for neuroangiographic procedures. Proceedings of the Joint Meeting of ASITN and AANS/CNS Cerebrovascular Section; Orlando,1998
-
Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
J Invasive Cardiol2001; 13
:354
362[Medline]
-
Carey D, Martin JR, Moore CA, Valentine MC, Nygaard TW. Complications of femoral artery closure devices.
Catheter Cardiovasc Interv2001; 52
:3
7[Medline]
-
Eidt JF, Habibipour S, Saucedo JF, et al. Surgical complications from hemostatic puncture closure devices.
Am J Surg1999; 178
:511
516[Medline]
-
Wong P, Harding S, Walters D, Hull ML, Jang IK. Vascular complications after hemostatic puncture closure device (Angio-Seal) are not higher in overweight patients.
J Invasive Cardiol2001; 13
:623
625[Medline]
-
Kussmaul WG, Buchbinder M, Whitlow PL, et al. Femoral artery hemostasis using an implantable device (Angio-Seal) after coronary angioplasty.
Cathet Cardiovasc Diagn1996; 37
:362
365[Medline]
-
Silber S, Schon N, Seidel N, Heiss-Bogner J. Accidental occlusion of the common femoral artery after Angio-Seal-application [in German].
Z Kardiol1998; 87
:51
55[Medline]
-
Stein BC, Teirstein PS. Nonsurgical removal of Angio-Seal device after intra-arterial deposition of collagen plug.
Catheter Cardiovasc Interv2000; 50
:340
342[Medline]
-
Warren BS, Warren SG, Miller SD. Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization.
Catheter Cardiovasc Interv1999; 48
:162
166[Medline]
-
de Swart H, Dijkman L, Hofstra L, et al. A new hemostatic puncture closure device for the immediate sealing of arterial puncture sites.
Am J Cardiol1993; 72
:445
449[Medline]
Received January 17, 2002;
accepted after revision March 17, 2002.
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Kirkwood, C.-M. Wahlgren, and T. R. Desai
The Use of Arterial Closure Devices for Incidental Arterial Injury
Vascular and Endovascular Surgery,
October 1, 2008;
42(5):
471 - 476.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nii, K. Kazekawa, M. Onizuka, H. Aikawa, M. Tsutsumi, M. Tomokiyo, M. Iko, T. Kodama, S. Matsubara, Y. Go, et al.
Direct Carotid Puncture for the Endovascular Treatment of Anterior Circulation Aneurysms
AJNR Am. J. Neuroradiol.,
August 1, 2006;
27(7):
1502 - 1504.
[Abstract]
[Full Text]
[PDF]
|
 |
|